Gabelli Healthcare & WellnessRx Trust Welcomes Jennie Tsai, Jing He, and Sara Wojda Portfolio Managers

Rhea-AI Summary

GAMCO Investors, Inc. (NYSE: GBL) has appointed Jennie Tsai, Jing He, and Sara Wojda to its Gabelli Healthcare & Wellness^Rx Trust (NYSE: GRX) investment team, effective January 1, 2021. Mr. Gabelli expressed confidence in their backgrounds, which include extensive experience in healthcare and biopharmaceuticals. The Gabelli Healthcare & Wellness^Rx Trust aims for long-term capital growth and has total net assets of $282 million. Investors are encouraged to consider the Fund’s investment objectives and risks before investing.

Positive

• The appointment of experienced professionals strengthens the investment team.
• The Fund has total net assets of $282 million, indicating solid financial backing.
• The diversified nature of the Fund supports long-term capital growth.

Negative

• None.

GAMCO Investors, Inc., (NYSE: GBL) announces the appointment of Jennie Tsai, Jing He, and Sara Wojda to the investment team of the Gabelli Healthcare & Wellness^Rx Trust (NYSE:GRX) (the “Fund”) effective January 1, 2021.

Commenting on the appointments, Mr. Gabelli said, “We are delighted to have Jennie, Jing, and Sara join the Healthcare & Wellness^Rx Trust team. They all have excellent foundations in Gabelli research that make them valuable additions to help our team meet the objectives of (y)our Fund.”

Jennie Tsai is a portfolio manager and analyst with 20 years’ experience investing in healthcare companies, specializing in medical devices. She joined Gabelli in 2001 after receiving an MBA from Columbia Business School and B.S. in Commerce from the University of Virginia.

Jing He is a portfolio manager and biotech analyst covering the biopharmaceutical industry. She joined Gabelli Funds in 2015 after receiving an MBA from Columbia Business School. Prior to that, she worked at Regeneron Pharmaceuticals as a scientist in drug research and development. She holds a Masters in Chemistry from Washington University in St. Louis and B.S. in Chemistry from Peking University.

Sara Wojda joined the firm in 2014 as a research analyst and covers the diagnostics and life sciences industries. Since moving to London in 2018, she has expanded the firm’s global healthcare coverage and assisted with the Gabelli U.K. based funds. Sara graduated summa cum laude from Babson College with a B.S. in Business Management, double-majoring in Economics and Accounting.

Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. More information regarding the Fund’s distribution policy and other information about the Fund is available by calling 800-GABELLI (800-422-3554) or visiting www.gabelli.com.

About The Gabelli Healthcare & Wellness^Rx Trust

The Gabelli Healthcare & Wellness^Rx Trust is a diversified, closed-end management investment company with $282 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (NYSE:GBL).

NYSE: GRX
CUSIP – 36246K103

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005728/en/

FAQ

What recent appointments were made by GAMCO Investors, Inc. regarding the Gabelli Healthcare & Wellness Trust?

GAMCO Investors, Inc. appointed Jennie Tsai, Jing He, and Sara Wojda to the investment team of the Gabelli Healthcare & Wellness Trust effective January 1, 2021.

What is the primary investment objective of the Gabelli Healthcare & Wellness Trust (NYSE: GRX)?

The primary investment objective of the Gabelli Healthcare & Wellness Trust is long-term growth of capital.

What are the total net assets of the Gabelli Healthcare & Wellness Trust?

The Gabelli Healthcare & Wellness Trust has total net assets of $282 million.

How can investors learn more about the Gabelli Healthcare & Wellness Trust?

Investors can learn more by calling 800-GABELLI or visiting www.gabelli.com.